Ccr5 Tropic Hiv 1 Infection Therapeutics
1. Selzentry patent expiration
Treatment: Method of treating patients infected with ccr5-tropic hiv-1
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6667314 | VIIV HLTHCARE | Tropane derivatives useful in therapy |
Aug, 2021
(4 years ago) | |
| US6586430 | VIIV HLTHCARE | CCR5 modulators |
Dec, 2019
(6 years ago) | |
| US7576097 | VIIV HLTHCARE | Tropane derivatives useful in therapy |
May, 2021
(4 years ago) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6667314 | VIIV HLTHCARE | Tropane derivatives useful in therapy |
Aug, 2021
(4 years ago) | |
|
US7576097 (Pediatric) | VIIV HLTHCARE | Tropane derivatives useful in therapy |
Nov, 2021
(4 years ago) | |
|
US7368460 (Pediatric) | VIIV HLTHCARE | Tropane derivatives useful in therapy |
May, 2023
(2 years ago) | |
| US6586430 | VIIV HLTHCARE | CCR5 modulators |
Dec, 2019
(6 years ago) | |
| US7368460 | VIIV HLTHCARE | Tropane derivatives useful in therapy |
Nov, 2022
(3 years ago) | |
| US7576097 | VIIV HLTHCARE | Tropane derivatives useful in therapy |
May, 2021
(4 years ago) | |
|
US6667314 (Pediatric) | VIIV HLTHCARE | Tropane derivatives useful in therapy |
Feb, 2022
(3 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Aug 06, 2012 |
| New Patient Population(NPP) | Oct 30, 2023 |
| New Product(NP) | Nov 04, 2019 |
| New Strength(NS) | Nov 04, 2019 |
| Pediatric Exclusivity(PED) | Apr 30, 2024 |
Drugs and Companies using MARAVIROC ingredient
NCE-1 date: 07 August, 2011
Market Authorisation Date: 04 November, 2016
Dosage: TABLET; SOLUTION
How can I launch a generic of SELZENTRY before it's drug patent expiration?
More Information on Dosage
SELZENTRY family patents
